Delivery Order SPE2DB20D1109-SPE2DB24FP56T

Award Date 7/24/24
Potential Completion Date 8/14/24
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 200-unit vials of the drug Xeomin. The contract has a firm fixed price of $6,155.52 and a completion date of January 18, 2023. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 200-unit vials of the drug Xeomin. The contract has a firm fixed price of $7,863.60 and a completion date of March 13, 2023. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing a comprehensive...
The Defense Logistics Agency (DLA) awarded a $1,425 firm fixed-price delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 50-unit vials of the drug Xeomin. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999, which provides a range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen also holds a...
This is a delivery order worth $3,145.50 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 200-unit vials of the pharmaceutical product Xeomin. The contract has a firm fixed-price pricing structure and a completion date of September 30, 2024. AmerisourceBergen is a large pharmaceutical distributor that holds multiple Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,106.25, is for the delivery of 200-unit vials of the pharmaceutical product Xeomin. The contract has a period of performance through May 16, 2024. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $10,484.80, is for the provision of 100 unit vials of the drug Xeomin. The award is not associated with a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $5,573.22 firm fixed price contract is for the delivery of 200-unit vials of the drug Xeomin. The contract has a period of performance through November 29, 2024 and was awarded on November 6, 2024. There was no set-aside designation for this award. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a $3,911.18 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 200-unit vials of the drug XEOMIN and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
This is a $3,145.44 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Xeomin 100 unit vials. The order has an ultimate completion date of October 1, 2024 and was awarded on September 10, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and runs through December 2025. The IDC enables the DLA to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $6,155.52 in Xeomin 200 unit vials. The award is a firm fixed-price contract with a completion date of January 17, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 for a comprehensive range of...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP56T
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 200-unit vials of the drug Xeomin. The $15,727.50 firm fixed-price contract has an ultimate completion date of August 14, 2024. It is not designated as a set-aside contract.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/27/25, 10:57 AM